Octapharma France

About Octapharma France

For over 40 years, Octapharma has become the world's largest independent, privately-owned plasma fractionation company. With over 11,000 dedicated employees, we provide high-quality, life-saving medicines derived from human plasma and human cell lines. Every day, we work to improve the lives of patients, creating deep meaning for our donors and employees. We support the treatment of patients in 120 countries. Our efforts focus on three therapeutic areas: immunotherapy, hematology, and intensive care. Octapharma operates seven R&D sites, five production facilities in Austria, France, Germany, and Sweden, and over 190 plasma donation centers in Europe and the United States. At the heart of our vision is a clear goal: to provide new health solutions that advance human life. We know our work changes the lives of millions. We feel the power of hope and strive every day to pass it on. Together, we contribute to a greater purpose – where we are all part of a vital chain. Our sites in France: Octapharma S.AS, Lingolsheim, France Octapharma France S.A.S, Paris, France